TW200510369A - Novel ethylenediamine derivatives - Google Patents
Novel ethylenediamine derivativesInfo
- Publication number
- TW200510369A TW200510369A TW092136696A TW92136696A TW200510369A TW 200510369 A TW200510369 A TW 200510369A TW 092136696 A TW092136696 A TW 092136696A TW 92136696 A TW92136696 A TW 92136696A TW 200510369 A TW200510369 A TW 200510369A
- Authority
- TW
- Taiwan
- Prior art keywords
- thrombosis
- syndrome
- infarction
- hydrogen
- represent
- Prior art date
Links
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical class NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 title 1
- 208000007536 Thrombosis Diseases 0.000 abstract 3
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 208000011580 syndromic disease Diseases 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010008088 Cerebral artery embolism Diseases 0.000 abstract 1
- 206010051055 Deep vein thrombosis Diseases 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 208000010378 Pulmonary Embolism Diseases 0.000 abstract 1
- 208000006193 Pulmonary infarction Diseases 0.000 abstract 1
- 206010038563 Reocclusion Diseases 0.000 abstract 1
- 206010047249 Venous thrombosis Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- 230000023555 blood coagulation Effects 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 230000004087 circulation Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000009190 disseminated intravascular coagulation Diseases 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 235000015220 hamburgers Nutrition 0.000 abstract 1
- 201000010849 intracranial embolism Diseases 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 230000007575 pulmonary infarction Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002373025 | 2002-12-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200510369A true TW200510369A (en) | 2005-03-16 |
Family
ID=32677247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW092136696A TW200510369A (en) | 2002-12-24 | 2003-12-24 | Novel ethylenediamine derivatives |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070129371A1 (zh) |
| EP (1) | EP1577302A4 (zh) |
| JP (1) | JP4601053B2 (zh) |
| KR (1) | KR20050092373A (zh) |
| CN (1) | CN1745071A (zh) |
| AU (1) | AU2003292748A1 (zh) |
| CA (1) | CA2511500A1 (zh) |
| IL (1) | IL169192A0 (zh) |
| MX (1) | MXPA05007012A (zh) |
| PL (1) | PL378215A1 (zh) |
| RU (1) | RU2005123390A (zh) |
| TW (1) | TW200510369A (zh) |
| WO (1) | WO2004058728A1 (zh) |
| ZA (1) | ZA200504813B (zh) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI290136B (en) * | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| WO2003000657A1 (fr) * | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
| EP1577301B1 (en) * | 2002-12-25 | 2012-09-12 | Daiichi Sankyo Company, Limited | Antithrombotic diaminocyclohexane derivatives |
| JP4759388B2 (ja) | 2003-11-12 | 2011-08-31 | 第一三共株式会社 | チアゾール誘導体の製造法 |
| US8032980B2 (en) | 2007-07-10 | 2011-10-11 | Mtd Products Inc | Harness for backpack blower |
| JP5422570B2 (ja) * | 2008-02-21 | 2014-02-19 | サノフイ | 凝固第Ｘａ因子及びトロンビンの阻害剤としてのクロロチオフェン−アミド類 |
| RS59255B1 (sr) | 2010-04-20 | 2019-10-31 | Fujifilm Toyama Chemical Co Ltd | Derivat hidroksaminske kiseline |
| US8539637B2 (en) | 2010-05-10 | 2013-09-24 | Mtd Products Inc | Harness for backpack blower |
| CN104402910B (zh) * | 2014-05-27 | 2017-02-08 | 斯芬克司药物研发（天津）股份有限公司 | 一种噻唑吡啶类化合物及其制备方法 |
| KR20180031037A (ko) | 2015-08-05 | 2018-03-27 | 브리스톨-마이어스 스큅 컴퍼니 | 신규 치환된 글리신 유도된 fxia 억제제 |
| KR102333564B1 (ko) | 2019-11-28 | 2021-12-01 | 동방에프티엘(주) | 광학 활성 다이아민 유도체 및 티아졸 유도체의 생산을 위한 새로운 합성경로 |
| WO2021110076A1 (zh) * | 2019-12-04 | 2021-06-10 | 深圳信立泰药业股份有限公司 | 草酰胺类衍生物、其制备方法及其在医药上的应用 |
| WO2022123319A1 (en) * | 2020-12-11 | 2022-06-16 | Ildong Pharmaceutical Co., Ltd. | Biased agonists of opioid receptors |
| CN114044742B (zh) * | 2021-11-26 | 2023-02-10 | 河北工业大学 | 手性伯胺丙二酰胺化合物及其制备方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5371072A (en) * | 1992-10-16 | 1994-12-06 | Corvas International, Inc. | Asp-Pro-Arg α-keto-amide enzyme inhibitors |
| EP0798295B1 (en) * | 1994-12-02 | 2003-02-26 | Yamanouchi Pharmaceutical Co. Ltd. | Novel amidinonaphthyl derivative or salt thereof |
| US6867299B2 (en) * | 2000-02-24 | 2005-03-15 | Hoffmann-La Roche Inc. | Oxamide IMPDH inhibitors |
| TWI290136B (en) * | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| WO2002030873A1 (fr) * | 2000-10-10 | 2002-04-18 | Fujisawa Pharmaceutical Co., Ltd. | Inhibiteur des mmp |
-
2003
- 2003-12-24 US US10/539,995 patent/US20070129371A1/en not_active Abandoned
- 2003-12-24 MX MXPA05007012A patent/MXPA05007012A/es unknown
- 2003-12-24 ZA ZA200504813A patent/ZA200504813B/xx unknown
- 2003-12-24 CA CA002511500A patent/CA2511500A1/en not_active Abandoned
- 2003-12-24 JP JP2004562907A patent/JP4601053B2/ja not_active Expired - Fee Related
- 2003-12-24 PL PL378215A patent/PL378215A1/pl not_active Application Discontinuation
- 2003-12-24 AU AU2003292748A patent/AU2003292748A1/en not_active Abandoned
- 2003-12-24 RU RU2005123390/04A patent/RU2005123390A/ru not_active Application Discontinuation
- 2003-12-24 EP EP03768148A patent/EP1577302A4/en not_active Withdrawn
- 2003-12-24 KR KR1020057011821A patent/KR20050092373A/ko not_active Application Discontinuation
- 2003-12-24 WO PCT/JP2003/016556 patent/WO2004058728A1/ja active Application Filing
- 2003-12-24 CN CNA2003801095437A patent/CN1745071A/zh active Pending
- 2003-12-24 TW TW092136696A patent/TW200510369A/zh unknown
-
2005
- 2005-06-15 IL IL169192A patent/IL169192A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL169192A0 (en) | 2008-02-09 |
| MXPA05007012A (es) | 2005-08-18 |
| AU2003292748A1 (en) | 2004-07-22 |
| PL378215A1 (pl) | 2006-03-20 |
| KR20050092373A (ko) | 2005-09-21 |
| US20070129371A1 (en) | 2007-06-07 |
| JP4601053B2 (ja) | 2010-12-22 |
| WO2004058728A1 (ja) | 2004-07-15 |
| RU2005123390A (ru) | 2006-01-27 |
| EP1577302A1 (en) | 2005-09-21 |
| JPWO2004058728A1 (ja) | 2006-04-27 |
| CA2511500A1 (en) | 2004-07-15 |
| EP1577302A4 (en) | 2010-09-01 |
| ZA200504813B (en) | 2006-10-25 |
| CN1745071A (zh) | 2006-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05006989A (es) | Derivados de diamina. | |
| MXPA04001272A (es) | Derivados de diamina. | |
| MXPA03011951A (es) | Derivados de diamina. | |
| TW200510369A (en) | Novel ethylenediamine derivatives | |
| MY153231A (en) | Diamine derivatives | |
| EP1583526B1 (de) | Acylierte 4-amidino- und 4-guanidinobenzylaminen zur inhibierung von plasmakallikrein | |
| ATE291013T1 (de) | Durch einen omega-thiarest substituierte phenyl- prostaglandin-e-derivate, verfahren zu ihrer herstellung und medikamente die diese als aktiven inhaltsstoff enthalten | |
| EA200100058A1 (ru) | 4-бензилпиперидиналкилсульфоксидные гетероциклические соединения и их применение в качестве подтип-избирательных антагонистов nmda-рецепторов | |
| PA8514401A1 (es) | Nuevos derivados de piperazina | |
| EA200401522A1 (ru) | Противотуберкулёзный препарат: композиции и способы | |
| PE20060317A1 (es) | Derivados de xantina como agonistas selectivos del receptor de acido nicotinico | |
| ES2119411T3 (es) | Combinaciones de proteinas y anticoagulantes tromboliticamente activos, y usos de los mismos. | |
| DK1180121T3 (da) | Langtidsvirkende insulinotrope peptider | |
| WO2010123290A3 (ko) | 체내 지속성을 유지함으로 체내 반감기가 증가된 단백질 또는 펩티드 융합체, 및 이를 이용하여 체내 반감기를 증가시키는 방법 | |
| FI962749A (fi) | Uusia heterosyklisiä yhdisteitä | |
| CY1108769T1 (el) | Αναστολεις της διπεπτιδυλικης πεπτιδασης iv για μειωση του ρυθμου της χρονιας αυξησης βαρους | |
| AR035890A1 (es) | Derivados de dipeptido con actividad inhibitoria de las enzimas convertidoras de angiotensina, de endotelina y de la enzima endopeptidasa neutra | |
| NO20050667L (no) | N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes | |
| DK1049700T3 (da) | Kemokinreceptorantagonister og fremgangsmåder til anvendelse deraf | |
| PE20061195A1 (es) | Derivado de bencimidazol como antagonista de angiotensina ii | |
| MXPA03008134A (es) | Compuesto de n-fenilarilsulfonamida, medicamento que contiene el compuesto como ingrediente activo, intermediario para el compuesto y procedimientos para su produccion. | |
| BRPI0506694A (pt) | análogos de peptìdeo-1 semelhante ao glucagon com longa duração de ação | |
| DK1377164T3 (da) | Erythropoietin forbedrer kemoterapi-induceret toksicitet in vivo | |
| DE50114771D1 (de) | Peptide und/oder Proteine sowie ihre Verwendung zur Herstellung eines therapeutischen und/oder präventiven Arzneimittels | |
| DE3783579T2 (de) | Derivate des alpha-anp und ihre herstellung. |